×

Cancer Drug Approval Rises Hopes For ImmunityBio, Dunkirk

A monumental achievement for ImmunityBio, Inc., occurred earlier this week, leaving the door open for potential major benefits to the Dunkirk community. Earlier this week,…

Starting at $3.50/week.

Subscribe Today